Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Norwegian Study of Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication Within Rheumatology and Gastroenterology: the Nor-vaC Study

NCT04798625 is registered in ClinicalTrials.gov with Diakonhjemmet Hospital as lead sponsor.

NCT NCT04798625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Norwegian Study of Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication Within Rheumatology and Gastroenterology: the Nor-vaC Study
Lead sponsor
Diakonhjemmet Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
February 15, 2021
Completion date
February 15, 2027
Enrollment
2,300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune hepatitis, crohn disease, liver transplant; complications, psoriatic arthritis, rheumatoid arthritis, spondyloarthritis, ulcerative colitis